(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: HEALTHCARE: John Crowley, CEO of Amicus Therapeutics, on expanding its pipeline of treatments for rare and orphan diseases.

Earnings Special: Nvidia's Sales Forecast Fails to Impress Wall Street
13:50

Meta Says It Will Pay Up to $18 Billion Over Social Media Claims
25:02

Dick’s Falls Most Ever With Chairman Saying More Pain to Come
23:49